Author:
Burstein Harold J.,Overmoyer Beth,Gelman Rebecca,Silverman Paula,Savoie Jennifer,Clarke Kathryn,Dumadag Leda,Younger Jerry,Ivy Percy,Winer Eric P.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference8 articles.
1. Prudhomme M (2003) Rebeccamycin analogues as anti-cancer agents. Eur J Med Chem 38:23–140
2. Merchant J, Tutsch K, Dresen A, Arzoomanian R, Alberti D, Feierabend C, Binger K, Marnoccha R, Thomas J, Cleary J, Wilding G (2002) Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats. Clin Cancer Res 8:2193–2201
3. Tocher AW, Beckahrdt SG, Kuhn J, Hammong L, Weiss G, Rizzo J, Aylesworth C, Hidalgo M, Putnik A, Schwartz G, Felton S, Campbell E, Rowinsky EK (2001) Phase 1 and pharmacokinetic study of NSC 655649, a rebeccamycin analogue with topoisomerase inhibitor properties. J Clin Oncol 19:2937–2947
4. Dowlati A, Hoppel CL, Ingalls ST, Majka S, Li X, Dedransk N, Spiro T, Gerson SL, Ivy P, Remick SC (2001) Phase I clinical and pharmacokinetic study of rebeccmycin analog NSC 655649 given daily for five consecutive days. J Clin Oncol 19:2309–2318
5. Therase P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205–216
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献